LLY vs PGEN · P/E 39, rev $22.97B vs rev $9.7M
Eli Lilly and Company (LLY) versus Precigen Inc (PGEN) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Precigen Inc (PGEN) is a biotechnology company listed on US.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported PGEN revenue for 2025-12-31 was $9.7M. Net income was -$250.6M. PGEN currently screens at market cap $419.2M.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. PGEN currently screens at market cap $419.2M.
Not investment advice. Open the LLY and PGEN stock pages for the full models.
Not investment advice.